Drug Type Small molecule drug |
Synonyms ADX-10059 |
Target |
Mechanism mGluR5 modulators(Metabotropic glutamate receptor 5 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13FN2 |
InChIKeyMEDCLNYIYBERKO-UHFFFAOYSA-N |
CAS Registry757950-09-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Raseglurant | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastroesophageal Reflux | Phase 2 | AT | 01 Dec 2008 | |
Gastroesophageal Reflux | Phase 2 | BE | 01 Dec 2008 | |
Gastroesophageal Reflux | Phase 2 | FR | 01 Dec 2008 | |
Gastroesophageal Reflux | Phase 2 | DE | 01 Dec 2008 | |
Gastroesophageal Reflux | Phase 2 | NL | 01 Dec 2008 | |
Gastroesophageal Reflux | Phase 2 | CH | 01 Dec 2008 | |
Migraine Disorders | Phase 2 | AT | 01 Dec 2008 | |
Migraine Disorders | Phase 2 | BE | 01 Dec 2008 | |
Migraine Disorders | Phase 2 | FR | 01 Dec 2008 | |
Migraine Disorders | Phase 2 | DE | 01 Dec 2008 |